Trivarx Ltd has released a press release.
Medibio Provides Update on FDA Process
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from TrivarX
- Medibio Appoints CEO and Managing Director
- MEB Signs ilumen Contract with Large Australian Employer
- Receipt of R&D Tax Incentive Refund
- Medibio Releases Corporate Health Product, ilumen
- Notice Received Under Section 249D of the Corporations Act
Later from TrivarX
- Response to ASX Appendix 4C Query
- Exclusive Agreement Signed for ilumen Pilot Program
- Converting Note & Non-Renounceable Entitlement Offer
- Ilumen Successfully Completes First Commercial Program
- Entitlement Issue Results and Shortfall Notification
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX